iTolerance & LyGenesis: Joint Research Collaboration to Regrow Functioning, Ectopic Livers Without Immune Suppression
iTolerance and LyGenesis announced a collaboration to evaluate the potential of iTOL-201 combined with LyGenesis' liver cell therapy (LYG-LIV-100), to enable ectopic livers to be grown without the need or immune...